aTyr Pharma, Inc.ATYRNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank62
5Y CAGR-15.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-15.2%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 10.32% |
| 2024 | -108.06% |
| 2023 | 20.69% |
| 2022 | -26.64% |
| 2021 | -116.16% |
| 2020 | 23.54% |
| 2019 | 35.57% |
| 2018 | 26.68% |
| 2017 | 19.86% |
| 2016 | -43.66% |